Eli Lilly Abandons Development of New Cholesterol Drug after Poor Performance in Phase 3 Trial
A Cholesterol Drug Fail To Perform Well. On Monday, drug maker Eli Lilly announced that it was ceasing work on a new cholesterol-lowering drug, after the drug failed to [...]